Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up Women only

Using aspirin to help women recover from severe preeclampsia after childbirth

Official title: Acetylsalicylic Acid for Postpartum Preeclampsia: A Pilot Randomized Trial

Run by MemorialCare Health System · NCT05924971 · Data updated 2026-11-12

This study tests if taking low-dose aspirin for a week after childbirth can help women recover faster from severe preeclampsia.

More Preeclampsia Postpartum trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment86 (estimated)
SponsorMemorialCare Health System
Academic / other
Locations1 site (Long Beach, California)
StatusRecruiting
StartedJuly 26, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 6, 2025
Trial IDNCT05924971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women diagnosed with severe preeclampsia during delivery who are receiving care from the specified medical facilities.

Probably not a fit

Patients under 18 years old, those with chronic hypertension prior to pregnancy, or those with contraindications to aspirin will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of low-dose aspirin on the recovery of women who have experienced severe preeclampsia during childbirth. The hypothesis is that aspirin will reduce levels of a protein called sFlt-1, which is linked to the condition, and help normalize blood pressure more quickly. Participants will take aspirin for the first week postpartum to assess its impact on their recovery. The study aims to address the lack of therapies targeting the underlying causes of postpartum preeclampsia.

Why it matters

Potential benefit: If successful, this approach could significantly improve recovery outcomes for women suffering from postpartum preeclampsia.

How similar studies have gone: While the approach of using aspirin in this context is novel, previous studies have shown aspirin's effectiveness in other pregnancy-related conditions, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Preeclampsia with severe features diagnosed during delivery admission, as defined by ACOG criteria.
* Pre- and postnatal care provided by the Long Beach Memorial Ob/Gyn resident or Maternal-Fetal Medicine clinic.

Exclusion Criteria:

* Patient age \<18 years old
* Non-English or Non-Spanish speaking
* Chronic hypertension diagnosed before 20 weeks' gestation
* Known allergy, prior adverse reaction, or any medical condition in which aspirin is contraindicated (nasal polyps, gastric or duodenal ulcers, history of gastrointestinal bleeding, severe hepatic dysfunction)
* Aspirin prescribed postpartum for any other medical condition
* Bleeding disorder
* Breastfeeding an infant with thrombocytopenia

Where it's running

  • Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach
    Long Beach, California, United States
    Recruiting

Study contacts

  • Principal investigator: Megan C Oakes, MD MSCI — Miller Children's and Women's Hospital, Long Beach/ MemorialCare Medical Center
  • Study coordinator: Megan C Oakes, MD MSCI
  • Email: moakes2@memorialcare.org
  • Phone: 562-997-8510

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.